Trial intelligence / Profile preview

Phase 1 study of formulation comparison and food effect for a new Janssen medicine in healthy participants

NL-OMON59334Phase 1Completed

Sponsor
Janssen Pharmaceutical
Start
Dec 2025
Countries
1
01

Overview

Phase 1 trial in psoriasis, sponsored by Janssen Pharmaceutical. Started Dec 2025; status: completed.

02

Conditions

psoriasis

Beyond the preview

Go deeper on NL-OMON59334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON59334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call